Michael Kaufmann, MD
Clinical Cardiac Electrophysiology · Huntsville, ALNPI 1629230297
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,372 of the $13,975 with a category attached, or 74.2%. 27 manufacturers reported payments, led by Boston Scientific at 24.5% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in AL, where the typical reported total is $17,214.
Across 421 payments — averaging $33.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Abbott$3K
- Merit Medical Systems Inc$2K
- Medtronic$1K
- Biosense Webster, Inc.$774
- Johnson & Johnson$554
- plus $3K from 21 others
What the payments were for
- Consulting fees$1,90014%
- Travel & lodging$1,70312%
- Food & beverage$10,37274%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 88 | $3,431 |
| Abbott | 73 | $3,204 |
| Merit Medical Systems Inc | 1 | $1,600 |
| Medtronic(2 entities) | 33 | $1,232 |
| Biosense Webster, Inc. | 23 | $774 |
| Johnson & Johnson | 34 | $554 |
| Novartis | 27 | $482 |
| Amgen | 26 | $414 |
| Novo Nordisk | 21 | $375 |
| Pfizer | 21 | $346 |
| Boehringer Ingelheim | 11 | $240 |
| AstraZeneca | 10 | $161 |
| Regeneron Healthcare Solutions, Inc. | 7 | $157 |
| E.r. Squibb & Sons, L.L.C. | 9 | $135 |
| Otsuka America Pharmaceutical, Inc. | 6 | $132 |
| Philips North America LLC | 1 | $124 |
| Bayer | 5 | $115 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $94 |
| United Therapeutics Corporation | 3 | $89 |
| Merck | 4 | $80 |
| Sanofi-aventis U.S. LLC | 4 | $75 |
| Scpharmaceuticals Inc. | 3 | $48 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| Lexicon Pharmaceuticals, Inc. | 1 | $22 |
| Bridgebio Pharma, Inc. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Elutia, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Worley Adv Coronary Sinus Guide$1,600
- GENERAL - STRUCTURAL HEART$1,094
- AVEIR$902
- Carto 3$328
- Advisor Catheter$300
- RESONATE EL ICD VR$221
- Micra$184
- ASSURITY$165
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$145
- SelectSecure$141
- Accent Pacemaker$140
- (9525) EP Undivided$124
- Attain$119
- Rhythmia Mapping System$114
- PulseSelect$109
- RESONATE$108
- ENSITE$105
How this compares
$13,975 in reported general payments places this provider in the 35th percentile of 42 clinical cardiac electrophysiology providers in Alabama.
See all clinical cardiac electrophysiology providers in Alabama →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 224 | $227,539 |
| MultaqDronedarone Hcl | 31 | $38,202 |
| XareltoRivaroxaban | 13 | $14,071 |
| Dofetilide | 37 | $6,347 |
| Flecainide Acetate | 66 | $3,908 |
| Amiodarone Hcl | 113 | $2,709 |
| Metoprolol Succinate | 79 | $1,388 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 24 | $1,218 |
| SotalolSotalol Hcl | 28 | $693 |
| Digoxin | 17 | $307 |
| Potassium Chloride | 14 | $254 |
| Pantoprazole Sodium | 39 | $235 |
| Metoprolol Tartrate | 25 | $173 |
| Carvedilol | 14 | $141 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $346 | $227,539224 claims |
| Sanofi-aventis U.S. LLCMultaq | $75 | $38,20231 claims |
| Johnson & JohnsonXarelto | $554 | $14,07113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 42 clinical cardiac electrophysiology providers in Alabama.
Other clinical cardiac electrophysiology in Huntsville
- Jeffery AllisonHuntsville$18K
- John JenningsHuntsville$15K
- Jay DinermanHuntsville$13K
- Paul TabereauxHuntsville$9K
- Hugh McElderryBirmingham$725K
- Anil RajendraBirmingham$495K
- Gustavo MoralesBirmingham$171K
- William MaddoxBirmingham$159K
- Francis BennBirmingham$95K
- Terence DunnBirmingham$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.